These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25418280)

  • 1. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.
    Peng L; Zhao Q; Li Q; Li M; Li C; Xu T; Jing X; Zhu X; Wang Y; Li F; Liu R; Zhong C; Pan Q; Zeng B; Liao Q; Hu B; Hu ZX; Huang YS; Sham P; Liu J; Xu S; Wang J; Gao ZL; Wang Y
    Hepatology; 2015 Apr; 61(4):1251-60. PubMed ID: 25418280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
    Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
    Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.
    Ezzikouri S; Chihab H; Elhabazi A; Wakrim L; Benjelloun S
    BMC Infect Dis; 2017 Jan; 17(1):99. PubMed ID: 28125961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive assessment showed no associations of variants at the SLC10A1 locus with susceptibility to persistent HBV infection among Southern Chinese.
    Zhang Y; Li Y; Wu M; Cao P; Liu X; Ren Q; Zhai Y; Xie B; Hu Y; Hu Z; Bei J; Ping J; Liu X; Yu Y; Guo B; Lu H; Liu G; Zhang H; Cui Y; Mo Z; Shen H; Zeng YX; He F; Zhang H; Zhou G
    Sci Rep; 2017 Apr; 7():46490. PubMed ID: 28429786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in the regulatory region of SLC10A1 are not associated with the risk of hepatitis B virus infection and clearance.
    Chen X; Wang Y; Chen X; Cheng K; Li J; Lou J; Ke J; Yang Y; Gong Y; Zhu Y; Wang L; Zhong R
    Infect Genet Evol; 2016 Oct; 44():495-500. PubMed ID: 27491457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake.
    Cheng X; Wang Y; Tian J; Zhou L; Chen X; Guo H; Zeng J; Shen N; Li J; Ke J; Zhu Y; Gong J; Chang J; Liu L; Zhong R
    J Viral Hepat; 2019 Oct; 26(10):1178-1185. PubMed ID: 31177598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine.
    Liu R; Chen C; Xia X; Liao Q; Wang Q; Newcombe PJ; Xu S; Chen M; Ding Y; Li X; Liao Z; Li F; Du M; Huang H; Dong R; Deng W; Wang Y; Zeng B; Pan Q; Jiang D; Zeng H; Sham P; Cao Y; Maxwell PH; Gao ZL; Peng L; Wang Y
    Sci Rep; 2017 Aug; 7(1):9214. PubMed ID: 28835676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
    Slijepcevic D; Kaufman C; Wichers CG; Gilglioni EH; Lempp FA; Duijst S; de Waart DR; Elferink RP; Mier W; Stieger B; Beuers U; Urban S; van de Graaf SF
    Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Expression of the Na
    Tremmel R; Nies AT; van Eijck BAC; Handin N; Haag M; Winter S; Büttner FA; Kölz C; Klein F; Mazzola P; Hofmann U; Klein K; Hoffmann P; Nöthen MM; Gaugaz FZ; Artursson P; Schwab M; Schaeffeler E
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg).
    Li H; Deng M; Guo L; Qiu JW; Lin GZ; Long XL; Xiao XM; Song YZ
    Mol Med Rep; 2019 Dec; 20(6):4915-4924. PubMed ID: 31661128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in sodium taurocholate cotransporting polypeptide are not associated with hepatitis B virus clearance in Chinese Tibetans and Uygurs.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Infect Genet Evol; 2016 Jul; 41():128-134. PubMed ID: 27051045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.
    An P; Zeng Z; Winkler CA
    J Infect Dis; 2018 Sep; 218(9):1404-1410. PubMed ID: 29905807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population.
    Nyarko E; Obirikorang C; Owiredu WKBA; Adu EA; Acheampong E; Aidoo F; Ofori E; Addy BS; Asare-Anane H
    Virol J; 2020 Jul; 17(1):91. PubMed ID: 32620148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency.
    Mao F; Liu T; Hou X; Zhao H; He W; Li C; Jing Z; Sui J; Wang F; Liu X; Han J; Borchers CH; Wang JS; Li W
    J Biol Chem; 2019 Aug; 294(31):11853-11862. PubMed ID: 31201272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.